Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency

Hypertension Research

Volumn 35, Issue 4, 2012, Pages 418-425

  Nakmareong, Saowanee ^a   Kukongviriyapan, Upa ^a   Pakdeechote, Poungrat ^a   Kukongviriyapan, Veerapol ^a   Kongyingyoes, Bunkerd ^a   Donpunha, Wanida ^a   Prachaney, Parichat ^a   Phisalaphong, Chada ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b Thailand Government Pharmaceutical Organization   (Thailand)

Author keywords

aortic elasticity; L NAME; nitric oxide; oxidative stress; tetrahydrocurcumin

Indexed keywords

ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; DRINKING WATER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRITE; SUPEROXIDE; TETRAHYDROCURCUMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AORTA; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; ATTENUATION; BLOOD PRESSURE; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFICACY; ELASTICITY; HEMODYNAMICS; HYPERTENSION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; VASCULAR RESISTANCE;

ANIMALS; AORTA; CURCUMIN; ENDOTHELIUM, VASCULAR; GLUTATHIONE; HEMODYNAMICS; HYPERTENSION; MALE; MALONDIALDEHYDE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDES; VASCULAR RESISTANCE; VASCULAR STIFFNESS;

EID: 84859610682     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2011.180     Document Type: Article

References (46)

1. Gardiner SM, Compton AM, Bennett T, Palmer RM, Moncada S. Control of regional blood flow by endothelium-derived nitric oxide. Hypertension 1990; 15: 486-492. (Pubitemid 20148039)
2. Wilkinson IB, Franklin SS, Cockcroft JR. Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology. Hypertension 2004; 44: 112-116. (Pubitemid 39014221)
3. Torok J. Participation of nitric oxide in different models of experimental hypertension. Physiol Res 2008; 57: 813-825.
4. Rauchova H, Pechanova O, Kunes J, Vokurkova M, Dobesova Z, Zicha J. Chronic Nacetylcysteine administration prevents development of hypertension in N(omega)-nitro- L-arginine methyl ester-treated rats: the role of reactive oxygen species. Hypertens Res 2005; 28: 475-482. (Pubitemid 41007463)
5. Toba H, Nakagawa Y, Miki S, Shimizu T, Yoshimura A, Inoue R, Asayama J, Kobara M, Nakata T. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine. Hypertens Res 2005; 28: 689-700. (Pubitemid 41601043)
6. Yang HY, Yang SC, Chen ST, Chen JR. Soy protein hydrolysate ameliorates cardiovascular remodeling in rats with L-NAME-induced hypertension. J Nutr Biochem 2008; 19: 833-839.
7. Duarte J, Jimenez R, O'Valle F, GalisteoM, Perez-Palencia R, Vargas F, Perez-Vizcaino F, Zarzuelo A, Tamargo J. Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats. J Hypertens 2002; 20: 1843-1854.
8. Priviero FB, Teixeira CE, Claudino MA, De Nucci G, Zanesco A, Antunes E. Vascular effects of long-term propranolol administration after chronic nitric oxide blockade. Eur J Pharmacol 2007; 571: 189-196. (Pubitemid 47379687)
9. Yamashita T, Yamamoto E, Kataoka K, Nakamura T, Matsuba S, Tokutomi Y, Dong YF, Ichijo H, Ogawa H, Kim-Mitsuyama S. Apoptosis signal-regulating kinase-1 is involved in vascular endothelial and cardiac remodeling caused by nitric oxide deficiency. Hypertension 2007; 50: 519-524. (Pubitemid 47312238)
10. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol 2007; 595: 1-75.
11. Khopde SM, Priyadarsini KI, Guha SN, Satav JG, Venkatesan P, Rao MN. Inhibition of radiation-induced lipid peroxidation by tetrahydrocurcumin: possible mechanisms by pulse radiolysis. Biosci Biotechnol Biochem 2000; 64: 503-509.
12. Somparn P, Phisalaphong C, Nakornchai S, Unchern S, Morales NP. Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biol Pharm Bull 2007; 30: 74-78. (Pubitemid 46066323)
13. Naito M, Wu X, Nomura H, Kodama M, Kato Y, Kato Y, Osawa T. The protective effects of tetrahydrocurcumin on oxidative stress in cholesterol-fed rabbits. J Atheroscler Thromb 2002; 9: 243-250.
14. Murugan P, Pari L. Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats. Life Sci 2006; 79: 1720-1728. (Pubitemid 44374550)
15. Pari L, Amali DR. Protective role of tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine induced hepatotoxicity in rats. J Pharm Pharm Sci 2005; 8: 115-123. (Pubitemid 41528877)
16. Ali MS, Mudagal MP, Goli D. Cardioprotective effect of tetrahydrocurcumin and rutin on lipid peroxides and antioxidants in experimentally induced myocardial infarction in rats. Pharmazie 2009; 64: 132-136.
17. Berry CL, Greenwald SE, Rivett JF. Static mechanical properties of the developing and mature rat aorta. Cardiovasc Res 1975; 9: 669-678.
18. Langewouters GJ, Wesseling KH, Goedhard WJ. The static elastic properties of 45 human thoracic and 20 abdominal aortas in vitro and the parameters of a new model. J Biomech 1984; 17: 425-435. (Pubitemid 14074069)
19. Greenwald SE. Pulse pressure and arterial elasticity. QJM 2002; 95: 107-112. (Pubitemid 34187785)
20. Luangaram S, Kukongviriyapan U, Pakdeechote P, Kukongviriyapan V, Pannangpetch P. Protective effects of quercetin against phenylhydrazine-induced vascular dysfunction and oxidative stress in rats. Food Chem Toxicol 2007; 45: 448-455. (Pubitemid 46176370)
21. Draper HH, Hadley M. A review of recent studies on the metabolism of exogenous and endogenous malondialdehyde. Xenobiotica 1990; 20: 901-907. (Pubitemid 20294520)
22. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994; 233: 357-363.
23. Sompamit K, Kukongviriyapan U, Nakmareong S, Pannangpetch P, Kukongviriyapan V. Curcumin improves vascular function and alleviates oxidative stress in non-lethal lipopolysaccharide-induced endotoxaemia in mice. Eur J Pharmacol 2009; 616: 192-199.
24. Verdon CP, Burton BA, Prior RL. Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite. Anal Biochem 1995; 224: 502-508.
25. Kukongviriyapan V, Somparn N, Senggunprai L, Prawan A, Kukongviriyapan U, Jetsrisuparb A. Endothelial dysfunction and oxidant status in pediatric patients with hemoglobin E-beta thalassemia. Pediatr Cardiol 2008; 29: 130-135.
26. Mukai Y, Sato S. Polyphenol-containing azuki bean (Vigna angularis) extract attenuates blood pressure elevation and modulates nitric oxide synthase and caveolin-1 expressions in rats with hypertension. Nutr Metab Cardiovasc Dis 2009; 19: 491-497.
27. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969; 27: 502-522.
28. Somparn N, Kukongviriyapan U, Tassaneeyakul W, Jetsrisuparb A, Kukongviriyapan V. Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients. Eur J Clin Pharmacol 2007; 63: 43-50. (Pubitemid 46025472)
29. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992; 90: 278-281.
30. Pereira LM, Bezerra DG, Mandarim-de-Lacerda CA. Aortic wall remodeling in rats with nitric oxide deficiency treated by enalapril or verapamil. Pathol Res Pract 2004; 200: 211-217. (Pubitemid 38950432)
31. Fitch RM, Vergona R, Sullivan ME, Wang YX. Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats. Cardiovasc Res 2001; 51: 351-358. (Pubitemid 32695546)
32. Hayashi K, Naiki T. Adaptation and remodeling of vascular wall; biomechanical response to hypertension. J Mech Behav Biomed Mater 2009; 2: 3-19.
33. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012. (Pubitemid 24015045)
34. Bernatova I, Pechanova O, Babal P, Kysela S, Stvrtina S, Andriantsitohaina R. Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. Am J Physiol Heart Circ Physiol 2002; 282: H942-H948. (Pubitemid 34654931)
35. Xu S, Touyz RM. Reactive oxygen species and vascular remodelling in hypertension: still alive. Can J Cardiol 2006; 22: 947-951.
36. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001; 38: 581-587.
37. Gonzalez W, Fontaine V, Pueyo ME, Laquay N, Messika-Zeitoun D, Philippe M, Arnal JF, Jacob MP, Michel JB. Molecular plasticity of vascular wall during N(G)-nitro-L-arginine methyl ester-induced hypertension: modulation of proinflammatory signals. Hypertension 2000; 36: 103-109. (Pubitemid 30602160)
38. De Gennaro Colonna V, Rossoni G, Rigamonti A, Bonomo S, Manfredi B, Berti F, Muller E. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats. Eur J Pharmacol 2002; 450: 61-66.
39. Simko F, Matuskova J, Luptak I, Krajcirovicova K, Kucharska J, Gvozdjakova A, Babal P, Pechanova O. Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension. Life Sci 2004; 74: 1211-1224. (Pubitemid 38022060)
40. Nakmareong S, Kukongviriyapan U, Pakdeechote P, Donpunha W, Kukongviriyapan V, Kongyingyoes B, Sompamit K, Phisalaphong C. Antioxidant and vascular protective effects of curcumin and n in rats with L-NAME-induced hypertension. Naunyn Schmiedebergs Arch Pharmacol 2011; 383: 519-529.
41. Pechanova O, Bernatova I, Babal P, Martinez MC, Kysela S, Stvrtina S, Andriantsitohaina R. Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension. J Hypertens 2004; 22: 1551-1559. (Pubitemid 39037607)
42. Pan MH, Lin-Shiau SY, Lin JK. Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages. Biochem Pharmacol 2000; 60: 1665-1676.
43. Kitamoto S, Egashira K, Kataoka C, Koyanagi M, Katoh M, Shimokawa H, Morishita R, Kaneda Y, Sueishi K, Takeshita A. Increased activity of nuclear factor-kappaB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats. Circulation 2000; 102: 806-812. (Pubitemid 30643289)
44. Gauss KA, Nelson-Overton LK, Siemsen DW, Gao Y, DeLeo FR, Quinn MT. Role of NFkappaB in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor-alpha. J Leukoc Biol 2007; 82: 729-741. (Pubitemid 47367165)
45. Anrather J, Racchumi G, Iadecola C. NF-kappaB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox. J Biol Chem 2006; 281: 5657-5667. (Pubitemid 43847663)
46. Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, Forstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002; 106: 1652-1658.